{"DataElement":{"publicId":"6930636","version":"1","preferredName":"Lesion Best Overall Response irRC Measurable Category","preferredDefinition":"The best overall disease response recorded from the start until the end of the study treatment taking into account any requirements for confirmation.","longName":"RSBOVRSP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6927206","version":"1","preferredName":"Disease Response Domain Lesion Best Overall Response","preferredDefinition":"A domain for disease response evaluations._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._The most clinically favorable response recorded from the start of the study treatment until the end of treatment.","longName":"6608777v1.0:6927204v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6927204","version":"1","preferredName":"Lesion Best Overall Response","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:The most clinically favorable response recorded from the start of the study treatment until the end of treatment.","longName":"C3824:C94536","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Best Overall Response","conceptCode":"C94536","definition":"The most clinically favorable response recorded from the start of the study treatment until the end of treatment.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"924EB6ED-1271-5B25-E053-F662850A7121","latestVersionIndicator":"Yes","beginDate":"2019-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-11","modifiedBy":"ONEDATA","dateModified":"2019-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"924EB6ED-1282-5B25-E053-F662850A7121","latestVersionIndicator":"Yes","beginDate":"2019-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-11","modifiedBy":"COOPERM","dateModified":"2020-06-04","changeDescription":"Created for CDSIC aligned NCI Standard CRFs. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6160013","version":"1","preferredName":"irRC Measurable Response Category","preferredDefinition":"Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. (Wolchok JD, Hoos A, O'Day S, Weber JS, Hamid O, Lebbe C, Maio M, Binder M, Bohnsack O, Nichol G, Humphrey R, Hodi FS. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. Clin Cancer Res. 2009 Dec 1;15(23):7412-20.)_Capable of being measured._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._A grouping of items based on some commonality or by user defined characteristics.","longName":"6160013v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"irCR","valueDescription":"irCR (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161693","version":"1","preferredName":"irCR (Immune-Related Response Criteria)","longName":"6161693","preferredDefinition":"Complete disappearance of all lesions (whether measurable or not, and no new lesions); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Complete Response","conceptCode":"C148193","definition":"Complete disappearance of all lesions (whether measurable or not, and no new lesions); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0B50-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F533A-F808-5967-E053-F662850A365F","beginDate":"2018-04-02","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"irPD","valueDescription":"irPD (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161694","version":"1","preferredName":"irPD (Immune-Related Response Criteria)","longName":"6161694","preferredDefinition":"Increase in tumor burden greater than or equal to 25 percent relative to nadir (minimum recorded tumor burden); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Progressive Disease","conceptCode":"C148196","definition":"Increase in tumor burden greater than or equal to 25 percent relative to nadir (minimum recorded tumor burden); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0B75-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F533A-F812-5967-E053-F662850A365F","beginDate":"2018-04-02","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"irPR","valueDescription":"irPR (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161695","version":"1","preferredName":"irPR (Immune-Related Response Criteria)","longName":"6161695","preferredDefinition":"Decrease in tumor burden greater than or equal to 50 percent relative to baseline confirmed by a consecutive assessment at least 4 weeks after first documentation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Partial Response","conceptCode":"C148194","definition":"Decrease in tumor burden greater than or equal to 50 percent relative to baseline confirmed by a consecutive assessment at least 4 weeks after first documentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0B9A-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F533A-F81C-5967-E053-F662850A365F","beginDate":"2018-04-02","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"irSD","valueDescription":"irSD (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161696","version":"1","preferredName":"irSD (Immune-Related Response Criteria)","longName":"6161696","preferredDefinition":"Not meeting criteria for irCR or irPR, in absence of irPD.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Stable Disease","conceptCode":"C148195","definition":"Not meeting criteria for irCR or irPR, in absence of irPD.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0BBF-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691CB836-559C-0AB1-E053-F662850A01FA","beginDate":"2017-10-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"NE","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3855538","version":"1","preferredName":"Unevaluable","longName":"3855538","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3F3FD8B-328D-C859-E040-BB89AD43580F","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F4496-0BE4-378D-E053-F662850AA125","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"2568055","version":"1","preferredName":"Not Done","longName":"2568055","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"REEVESD","dateModified":"2014-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F4496-0BEE-378D-E053-F662850AA125","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6160012","version":"1","preferredName":"Wolchok Solid Tumors 2009 Oncology Response Criteria Measurable Response Category","preferredDefinition":"Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. (Wolchok JD, Hoos A, O'Day S, Weber JS, Hamid O, Lebbe C, Maio M, Binder M, Bohnsack O, Nichol G, Humphrey R, Hodi FS. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. Clin Cancer Res. 2009 Dec 1;15(23):7412-20.):Capable of being measured.:Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C126051:C37894:C25755:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wolchok Solid Tumors 2009 Oncology Response Criteria","conceptCode":"C126051","definition":"A measure proposed by Wolchok et al. (Clin Cancer Res 2009;15:7412-7420) to determine the extent of an antitumor response to a particular immunotherapeutic agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Measurable","conceptCode":"C37894","definition":"Capable of being measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68E24E85-529F-33CF-E053-F662850A96DC","latestVersionIndicator":"Yes","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-02","modifiedBy":"ONEDATA","dateModified":"2018-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRC: Immune-Related Response Criteria-2009","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"68E24E85-52B0-33CF-E053-F662850A96DC","latestVersionIndicator":"Yes","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-02","modifiedBy":"KNABLEJ","dateModified":"2018-10-23","changeDescription":"10/23/18 jk chg reg status to Standard for RECIST defined PV list; do not add PVs without checking latest version of guideline.  4/2/18 jk created for DCI study and immune RECIST FG activities.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6921972","version":"1","longName":"RECIST - CDISC Aligned ","context":"NCI Standards"},{"publicId":"6921973","version":"1","longName":"irRC - CDISC Aligned","context":"NCI Standards"}]},{"publicId":"7434158","version":"1","longName":"CTEP CDISC Harmonization","context":"CTEP","ClassificationSchemeItems":[{"publicId":"7590130","version":"1","longName":"CTEP CDISC irRC","context":"CTEP"}]}],"AlternateNames":[{"name":"RS_RSORRES_BESTRESP_IRRC","type":"CTEP CDISC CDE","context":"CTEP"}],"ReferenceDocuments":[{"name":"Best overall response","type":"Preferred Question Text","description":"Best overall response","url":null,"context":"NCI Standards"},{"name":"CTEP Text 1","type":"Alternate Question Text","description":"What was the best overall response?","url":null,"context":"CTEP"},{"name":"CTEP Text 2","type":"Alternate Question Text","description":"Best overall response","url":null,"context":"CTEP"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"924EB6ED-129F-5B25-E053-F662850A7121","latestVersionIndicator":"Yes","beginDate":"2019-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-11","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Released. AK 2020-8-31 Created for CDISC aligned NCI Standard CRF task. mc","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}